A new paper explores the topic of proprietary blends in dietary supplements, with one of the authors noting that industry needs to take a position on an issue that pits transparency on one side against intellectual property protection on the other.
As the ChromaDex External Research Program passes a significant milestone with 250 material transfer agreements (MTAs), are there lessons for the rest of the industry to learn about building out R&D programs?
Indian-American ingredient supplier Sabinsa has announced it now has more than 300 patents granted on its ingredients and their uses. The company says the milestone is a demonstration of its commitment to the quality of its products and the scientific...
An upcoming webinar will explore the taxonomic changes to the genus Lactobacillus and the implications for brands, from labeling to consumer education.
